Ryoncil® Sales Increase 60% in December Quarter to US$35.1M

Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year FacilityNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular ...
University of California

Rewriting the code: The inside story of the first CRISPR cure

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's ...